Liver Disease Diagnosis and Treatment
Liver Disease Diagnosis and Treatment is a research topic within Epidemiology. Science Explorer counts 122k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.
- NAFLD
- NASH
- Liver Fibrosis
- Insulin Resistance
- Hepatic Steatosis
- Liver Biopsy
- Metabolic Syndrome
- Fatty Liver
- Hepatocellular Carcinoma
- Non-invasive Assessment
- Research works
- 122k fractional, since 1950
- In the world top 10%
- 12k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +25% the tick is no change
- Largest producer
China
35% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Liver Disease Diagnosis and Treatment research?
By volume, China and the United States publish the most (6.5k and 4.5k works in 2022-now).
By volume, 2022-now
- 1
China 6.5k works
- 2
United States 4.5k works
- 3
India 2k works
- 4
Japan 1k works
- 5
Italy 893 works
- 6
South Korea 873 works
- 7
Egypt 837 works
- 8
United Kingdom 816 works
- 9
Germany 735 works
- 10
Spain 585 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Liver Disease Diagnosis and Treatment research?
By volume in 2022-now, Sun Yat-sen University publishes the most Liver Disease Diagnosis and Treatment research, followed by Capital Medical University and Harvard University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 184 works
- 2
Capital Medical University
China 169 works
- 3
Harvard University
United States 156 works
- 4
Shanghai Jiao Tong University
China 149 works
- 5
Sichuan University
China 147 works
- 6
Zhejiang University
China 141 works
- 7
Ain Shams University
Egypt 132 works
- 8
Fudan University
China 119 works
- 9
Peking University
China 106 works
- 10
Yonsei University
South Korea 104 works
Who are the leading researchers in Liver Disease Diagnosis and Treatment?
The most-cited researchers publishing on Liver Disease Diagnosis and Treatment include Douglas G. Altman, Ahmedin Jemal and Christopher J L Murray.
- 1
Douglas G. Altman
United Kingdom 862k citations
- 2
Ahmedin Jemal
United States 761k citations
- 3
Christopher J L Murray
United States 583k citations
- 4
Freddie Bray
France 550k citations
- 5
Eric S. Lander
United States 524k citations
- 6
Zhong Lin Wang
United States 491k citations
- 7
Jacques Ferlay
France 486k citations
- 8
Rob Knight
United States 468k citations
- 9
Simon Iain Hay
United States 452k citations
- 10
George Davey Smith
United Kingdom 435k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Liver Disease Diagnosis and Treatment research done?
The largest centres of Liver Disease Diagnosis and Treatment research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shibīn al Kawm.
Largest cities, 2022-now
Where it is the local speciality
- Shibīn al KawmEG · 65.0 works11×
Location quotient: how much more of its research is in Liver Disease Diagnosis and Treatment than the world average.
Where is the best place to study Liver Disease Diagnosis and Treatment?
Among universities, judged by research, University of California San Diego, Harvard University and Wenzhou Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Liver Disease Diagnosis and Treatment, country by countryIs Liver Disease Diagnosis and Treatment research growing?
Output in 2022-2025 was 25% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Liver Disease Diagnosis and Treatment.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Liver Disease Diagnosis and Treatment as a percentage of every work published that year, 0.13% in 2024.
Fractional works of Liver Disease Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Liver Disease Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.